Clinical trial
PROTEUS: A PROspective Randomised Controlled Trial Evaluating the Use of Artificial Intelligence in Stress Echocardiology
NCT05028179 is registered in ClinicalTrials.gov with Ultromics Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PROTEUS: A PROspective Randomised Controlled Trial Evaluating the Use of Artificial Intelligence in Stress Echocardiology
- Lead sponsor
- Ultromics Ltd
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 8, 2021
- Completion date
- December 31, 2023
- Enrollment
- 2,338 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
coronary heart disease